Peter Webster
Associate Director of Analytical Science and Technology (AS&T), Solid Bio
Peter Webster is listed as Associate Director of Analytical Science and Technology (AS&T), Solid Bio. Peter is scheduled to speak at Advanced Therapies Week 2027 on 20 January 2027.
Compiled from published conference agendas; not yet confirmed by Peter. Is this you? Claim this profile.
About
Peter Webster serves as Associate Director of Analytical Science & Technology at Solid Biosciences Inc., where he provides leadership for analytical strategies supporting the development of gene therapy products. With a background in analytical development, he has led efforts in assay development, method validation, product characterization, and comparability testing for advanced therapies. Peter's expertise includes the application of analytical control strategies to support clinical and commercial manufacturing, regulatory submissions, and lifecycle management activities. He is passionate about advancing innovative analytical approaches that enable the efficient development and commercialization of transformative genetic medicines.
Upcoming
Advanced Therapies Week 2027 19 January 2027 – 21 January 2027
- Panel discussion Speaker · 20 January 2027
- Session 7: The more we learn the less we know. How can we leverage an increasingly high-resolution picture of viral vector quality to the benefit of gene therapy product consistency and safety? Speaker · 20 January 2027
- Spotlight: Designing analytical comparability assessments for process and manufacturing changes Speaker · 20 January 2027
Spoke alongside
People who have shared a session with Peter at events on B2DB.
- Kyle Carter Senior Director, Quality, Data Systems and Data Processes · Kite Pharma 2 shared sessions